TMEM176B
gene geneOn this page
Also known as LR8MS4B2
Summary
TMEM176B (transmembrane protein 176B, HGNC:29596) is a protein-coding gene on chromosome 7q36.1, encoding Transmembrane protein 176B (Q3YBM2). May play a role in the process of maturation of dendritic cells.
Predicted to be involved in negative regulation of dendritic cell differentiation. Predicted to be located in nuclear membrane.
Source: NCBI Gene 28959 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 58 total — 1 pathogenic
- MANE Select transcript:
NM_001101312
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:29596 |
| Approved symbol | TMEM176B |
| Name | transmembrane protein 176B |
| Location | 7q36.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | LR8, MS4B2 |
| Ensembl gene | ENSG00000106565 |
| Ensembl biotype | protein_coding |
| OMIM | 610385 |
| Entrez | 28959 |
Gene structure
Transcript identifiers
Ensembl transcripts: 88 — 88 protein_coding
ENST00000326442, ENST00000429904, ENST00000447204, ENST00000450753, ENST00000492607, ENST00000854800, ENST00000854801, ENST00000854803, ENST00000854804, ENST00000854805, ENST00000854806, ENST00000854807, ENST00000854808, ENST00000854809, ENST00000854810, ENST00000854811, ENST00000854812, ENST00000854813, ENST00000854814, ENST00000854815, ENST00000854816, ENST00000854817, ENST00000854818, ENST00000854819, ENST00000854820, ENST00000854821, ENST00000854822, ENST00000854823, ENST00000854824, ENST00000854825, ENST00000854826, ENST00000854827, ENST00000854828, ENST00000854829, ENST00000854830, ENST00000854831, ENST00000854832, ENST00000854833, ENST00000854834, ENST00000854835, ENST00000854836, ENST00000854837, ENST00000854838, ENST00000854839, ENST00000854840, ENST00000854841, ENST00000854842, ENST00000854843, ENST00000854844, ENST00000854845, ENST00000854846, ENST00000854847, ENST00000854848, ENST00000854849, ENST00000854850, ENST00000854851, ENST00000854852, ENST00000854853, ENST00000854854, ENST00000854855, ENST00000854856, ENST00000854857, ENST00000854858, ENST00000854859, ENST00000854860, ENST00000854861, ENST00000854862, ENST00000854863, ENST00000854864, ENST00000854865, ENST00000854866, ENST00000854867, ENST00000854868, ENST00000854869, ENST00000854870, ENST00000854871, ENST00000854872, ENST00000854873, ENST00000854874, ENST00000854875, ENST00000854876, ENST00000854877, ENST00000854878, ENST00000854879, ENST00000854880, ENST00000956466, ENST00000956467, ENST00000956468
RefSeq mRNA: 6 — MANE Select: NM_001101312
NM_001101311, NM_001101312, NM_001101314, NM_001362691, NM_001362692, NM_014020
CCDS: CCDS47746, CCDS5908
Canonical transcript exons
ENST00000326442 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000729864 | 150793544 | 150793600 |
| ENSE00000729866 | 150793961 | 150794071 |
| ENSE00000872377 | 150796366 | 150796574 |
| ENSE00001929051 | 150791301 | 150791623 |
| ENSE00001956871 | 150800298 | 150800364 |
| ENSE00002251909 | 150793088 | 150793315 |
| ENSE00002305287 | 150792056 | 150792175 |
Expression profiles
Bgee: expression breadth ubiquitous, 264 present calls, max score 99.71.
FANTOM5 (CAGE): breadth broad, TPM avg 22.8806 / max 1156.1802, expressed in 607 samples.
FANTOM5 promoters (7 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 86815 | 19.1947 | 594 |
| 86820 | 1.8134 | 303 |
| 86822 | 1.5670 | 288 |
| 86821 | 0.1320 | 61 |
| 86823 | 0.0643 | 42 |
| 86816 | 0.0564 | 22 |
| 86817 | 0.0529 | 30 |
Top tissues by expression
283 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right lobe of liver | UBERON:0001114 | 99.71 | gold quality |
| liver | UBERON:0002107 | 99.44 | gold quality |
| granulocyte | CL:0000094 | 99.34 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 99.21 | gold quality |
| gall bladder | UBERON:0002110 | 99.08 | gold quality |
| rectum | UBERON:0001052 | 98.95 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 98.77 | gold quality |
| ileal mucosa | UBERON:0000331 | 98.76 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 98.76 | gold quality |
| caecum | UBERON:0001153 | 98.70 | gold quality |
| vermiform appendix | UBERON:0001154 | 98.67 | gold quality |
| transverse colon | UBERON:0001157 | 98.50 | gold quality |
| metanephros cortex | UBERON:0010533 | 98.50 | gold quality |
| decidua | UBERON:0002450 | 98.46 | gold quality |
| small intestine | UBERON:0002108 | 98.32 | gold quality |
| right atrium auricular region | UBERON:0006631 | 98.13 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 98.05 | gold quality |
| colonic mucosa | UBERON:0000317 | 98.01 | gold quality |
| left ovary | UBERON:0002119 | 97.91 | gold quality |
| cardiac atrium | UBERON:0002081 | 97.87 | gold quality |
| dorsal root ganglion | UBERON:0000044 | 97.86 | gold quality |
| renal medulla | UBERON:0000362 | 97.80 | gold quality |
| islet of Langerhans | UBERON:0000006 | 97.77 | gold quality |
| right ovary | UBERON:0002118 | 97.75 | gold quality |
| large intestine | UBERON:0000059 | 97.65 | gold quality |
| saphenous vein | UBERON:0007318 | 97.65 | gold quality |
| intestine | UBERON:0000160 | 97.62 | gold quality |
| colon | UBERON:0001155 | 97.62 | gold quality |
| duodenum | UBERON:0002114 | 97.37 | gold quality |
| tibial nerve | UBERON:0001323 | 97.35 | gold quality |
Single-cell (SCXA)
Detected in 26 experiment(s), a significant marker in 26.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-9906 | yes | 1486.44 |
| E-GEOD-81547 | yes | 1259.97 |
| E-GEOD-81608 | yes | 925.59 |
| E-CURD-55 | yes | 857.81 |
| E-ENAD-27 | yes | 856.65 |
| E-GEOD-149689 | yes | 831.50 |
| E-MTAB-9154 | yes | 624.93 |
| E-ANND-5 | yes | 516.37 |
| E-MTAB-8221 | yes | 471.42 |
| E-HCAD-38 | yes | 466.49 |
| E-HCAD-56 | yes | 274.60 |
| E-CURD-122 | yes | 67.87 |
| E-HCAD-11 | yes | 58.72 |
| E-HCAD-31 | yes | 57.15 |
| E-HCAD-1 | yes | 43.01 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
31 targeting TMEM176B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-3617-3P | 99.98 | 67.86 | 918 |
| HSA-MIR-4745-5P | 99.98 | 65.95 | 1028 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-3150A-3P | 99.76 | 64.44 | 1640 |
| HSA-MIR-6763-5P | 99.76 | 64.68 | 1767 |
| HSA-MIR-7157-5P | 99.66 | 69.33 | 1829 |
| HSA-MIR-3175 | 99.65 | 66.30 | 2031 |
| HSA-MIR-4516 | 99.61 | 67.78 | 3390 |
| HSA-MIR-4310 | 99.59 | 68.84 | 2527 |
| HSA-MIR-6833-5P | 99.50 | 68.93 | 1161 |
| HSA-MIR-491-5P | 99.13 | 65.98 | 1468 |
| HSA-MIR-4434 | 99.10 | 67.01 | 1984 |
| HSA-MIR-5703 | 99.10 | 67.09 | 2053 |
| HSA-MIR-589-5P | 98.72 | 66.96 | 927 |
| HSA-MIR-3187-5P | 98.36 | 65.74 | 1776 |
| HSA-MIR-4782-5P | 98.35 | 69.33 | 1474 |
| HSA-MIR-5706 | 98.35 | 69.33 | 1463 |
| HSA-MIR-1285-3P | 97.72 | 67.02 | 1932 |
| HSA-MIR-5189-5P | 97.72 | 66.96 | 1814 |
| HSA-MIR-612 | 97.26 | 65.95 | 1597 |
| HSA-MIR-6860 | 97.21 | 66.31 | 1656 |
| HSA-MIR-4445-5P | 97.21 | 66.16 | 832 |
| HSA-MIR-34A-3P | 96.80 | 67.70 | 805 |
| HSA-MIR-6839-5P | 96.74 | 68.29 | 1088 |
| HSA-MIR-378J | 96.44 | 66.20 | 1020 |
| HSA-MIR-6742-5P | 96.32 | 64.01 | 869 |
| HSA-MIR-6796-5P | 95.37 | 66.08 | 1120 |
| HSA-MIR-4466 | 92.97 | 63.23 | 39 |
Literature-anchored findings (GeneRIF, showing 5)
- human TMEM176A and 176B protein levels are significantly elevated in lymphoma, but not in normal tissues (PMID:22244448)
- Study characterized Tmem176a and b expression in RORgamma t+ lymphocytes at transcriptional and protein levels and present evidence that both genes exert a redundant ion channel function related to a colocalisation in close proximity to the Golgi apparatus. (PMID:27009467)
- TMEM176A and TMEM176B Are Candidate Regulators of Inhibition of Dendritic Cell Maturation and Function after Chronic Spinal Cord Injury. (PMID:31354034)
- TMEM176B Regulates AKT/mTOR Signaling and Tumor Growth in Triple-Negative Breast Cancer. (PMID:34943938)
- The Ala134Thr variant in TMEM176B exerts a beneficial role in colorectal cancer prognosis by increasing NLRP3 inflammasome activation. (PMID:35980484)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tmem176b | ENSMUSG00000029810 |
| rattus_norvegicus | Tmem176b | ENSRNOG00000008465 |
Paralogs (1): TMEM176A (ENSG00000002933)
Protein
Protein identifiers
Transmembrane protein 176B — Q3YBM2 (reviewed: Q3YBM2)
Alternative names: Protein LR8
All UniProt accessions (2): Q3YBM2, A0A090N7V7
UniProt curated annotations — full annotation on UniProt →
Function. May play a role in the process of maturation of dendritic cells. Required for the development of cerebellar granule cells.
Subcellular location. Nucleus membrane.
Tissue specificity. Expressed in lung and dermal fibroblasts.
Induction. Up-regulated in fibrotic lung. Down-regulated in activated dendritic cells.
Similarity. Belongs to the TMEM176 family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q3YBM2-1 | 1 | yes |
| Q3YBM2-2 | 2 |
RefSeq proteins (6): NP_001094781, NP_001094782, NP_001094784, NP_001349620, NP_001349621, NP_054739 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007237 | CD20-like_TM | Domain |
| IPR009281 | TMEM176A/TMEM176B | Family |
Pfam: PF04103
UniProt features (20 total): sequence variant 6, transmembrane region 4, modified residue 4, sequence conflict 2, chain 1, splice variant 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3YBM2-F1 | 69.72 | 0.16 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (4): 258, 236, 245, 254
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 281 (showing top):
GOBP_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT, GOBP_DENDRITIC_CELL_DIFFERENTIATION, GOBP_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION, GNF2_GSTM1, GNF2_HPN, GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN, JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP, FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN, TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP, TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP, GOBP_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION, PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP, GOBP_ANIMAL_ORGAN_MORPHOGENESIS, GOBP_REGULATION_OF_HEMOPOIESIS, GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS
GO Biological Process (4): animal organ morphogenesis (GO:0009887), dendritic cell differentiation (GO:0097028), negative regulation of dendritic cell differentiation (GO:2001199), cell differentiation (GO:0030154)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (3): nuclear membrane (GO:0031965), nucleus (GO:0005634), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| anatomical structure morphogenesis | 1 |
| animal organ development | 1 |
| mononuclear cell differentiation | 1 |
| dendritic cell differentiation | 1 |
| negative regulation of leukocyte differentiation | 1 |
| regulation of dendritic cell differentiation | 1 |
| cellular developmental process | 1 |
| binding | 1 |
| nucleus | 1 |
| nuclear envelope | 1 |
| organelle membrane | 1 |
| intracellular membrane-bounded organelle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1516 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM176B | SP9 | P0CG40 | 542 |
| TMEM176B | ZNF775 | Q96BV0 | 482 |
| TMEM176B | ACRV1 | P26436 | 475 |
| TMEM176B | APOE | P02649 | 474 |
| TMEM176B | BCLAF1 | Q9NYF8 | 453 |
| TMEM176B | CPXM1 | Q96SM3 | 433 |
| TMEM176B | GDAP1L1 | Q96MZ0 | 416 |
| TMEM176B | TMEM47 | Q9BQJ4 | 411 |
| TMEM176B | GIMAP8 | Q8ND71 | 409 |
| TMEM176B | GIMAP6 | Q6P9H5 | 409 |
| TMEM176B | THBS4 | P35443 | 405 |
| TMEM176B | KLF9 | Q13886 | 402 |
| TMEM176B | MS4A18 | Q3C1V0 | 397 |
| TMEM176B | LGALS3 | P17931 | 394 |
| TMEM176B | IL17RC | Q8NAC3 | 388 |
IntAct
25 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMEM176B | TMEM176A | psi-mi:“MI:0915”(physical association) | 0.560 |
| LAMP2 | TMEM176B | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM176B | PRKCA | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM176B | YWHAG | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM176B | SETDB1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TMEM176B | KAT5 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LMO3 | TMEM176B | psi-mi:“MI:0915”(physical association) | 0.560 |
| SHANK3 | IGKV3D-15 | psi-mi:“MI:0914”(association) | 0.350 |
| TMEM176B | IGLL5 | psi-mi:“MI:0914”(association) | 0.350 |
| TMEM176B | TMEM176A | psi-mi:“MI:0915”(physical association) | 0.000 |
| TMEM176B | repS | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (26): TMEM176B (PCA), TMEM176B (Two-hybrid), TMEM176B (PCA), IGHM (Affinity Capture-MS), LACRT (Affinity Capture-MS), IGLL5 (Affinity Capture-MS), BPIFB1 (Affinity Capture-MS), RBM45 (Affinity Capture-MS), IGLC2 (Affinity Capture-MS), LTF (Affinity Capture-MS), PIGR (Affinity Capture-MS), SCGB2A1 (Affinity Capture-MS), IGJ (Affinity Capture-MS), IGHA1 (Affinity Capture-MS), SERPINA3 (Affinity Capture-MS)
ESM2 similar proteins: A0A087WTH1, A0A125YWU9, A0PK84, A6PVL3, C9JQL5, F1QHM7, F1QX91, O15503, O41933, O70418, O88728, P0DI73, P13164, P26376, Q01628, Q01629, Q08755, Q0II74, Q21642, Q32L65, Q3UNB8, Q3YBM2, Q5FVR1, Q5FWL7, Q5I0I2, Q5R8D6, Q5RF75, Q5Y5T3, Q6DHI1, Q76IC6, Q7M734, Q7TQJ1, Q8BGI3, Q8CES1, Q8CFA6, Q8IYP9, Q8N6L7, Q8WVZ1, Q91WU6, Q921C1
Diamond homologs: Q3YBM2, Q4G068, Q5R8D6, Q7YQI4, Q925D4, Q96HP8, Q9DCS1, Q9R1Q6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
58 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 36 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 2685275 | GRCh37/hg19 7q36.1(chr7:148538593-150967829)x1 | Pathogenic |
SpliceAI
2306 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:150792050:ACT:A | donor_loss | 1.0000 |
| 7:150792051:CTC:C | donor_loss | 1.0000 |
| 7:150792053:CACC:C | donor_loss | 1.0000 |
| 7:150792054:ACCA:A | donor_loss | 1.0000 |
| 7:150792171:AACTT:A | acceptor_gain | 1.0000 |
| 7:150792173:CTT:C | acceptor_gain | 1.0000 |
| 7:150792174:TT:T | acceptor_gain | 1.0000 |
| 7:150792175:TCTG:T | acceptor_loss | 1.0000 |
| 7:150792176:C:CC | acceptor_gain | 1.0000 |
| 7:150792176:CTG:C | acceptor_loss | 1.0000 |
| 7:150792182:A:AC | acceptor_gain | 1.0000 |
| 7:150792182:A:C | acceptor_gain | 1.0000 |
| 7:150793033:C:CA | donor_gain | 1.0000 |
| 7:150793078:T:TA | donor_gain | 1.0000 |
| 7:150793086:AC:A | donor_gain | 1.0000 |
| 7:150793087:CC:C | donor_gain | 1.0000 |
| 7:150793119:T:TA | donor_gain | 1.0000 |
| 7:150793311:TAGCC:T | acceptor_gain | 1.0000 |
| 7:150793538:ACTC:A | donor_loss | 1.0000 |
| 7:150793539:CTC:C | donor_loss | 1.0000 |
| 7:150793540:TCA:T | donor_loss | 1.0000 |
| 7:150793541:CA:C | donor_loss | 1.0000 |
| 7:150793542:A:AC | donor_gain | 1.0000 |
| 7:150793542:ACAG:A | donor_gain | 1.0000 |
| 7:150793543:C:CG | donor_gain | 1.0000 |
| 7:150793543:CA:C | donor_gain | 1.0000 |
| 7:150793543:CAG:C | donor_gain | 1.0000 |
| 7:150793543:CAGC:C | donor_gain | 1.0000 |
| 7:150793543:CAGCA:C | donor_gain | 1.0000 |
| 7:150793597:TCAC:T | acceptor_gain | 1.0000 |
AlphaMissense
1723 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:150794042:A:C | S78R | 0.966 |
| 7:150794042:A:T | S78R | 0.966 |
| 7:150794044:T:G | S78R | 0.966 |
| 7:150794053:C:G | G75R | 0.929 |
| 7:150794053:C:T | G75R | 0.929 |
| 7:150793241:G:C | S149R | 0.927 |
| 7:150793241:G:T | S149R | 0.927 |
| 7:150793243:T:G | S149R | 0.927 |
| 7:150793975:A:G | W101R | 0.925 |
| 7:150793975:A:T | W101R | 0.925 |
| 7:150794041:A:G | C79R | 0.898 |
| 7:150794052:C:T | G75E | 0.889 |
| 7:150792136:A:G | C214R | 0.878 |
| 7:150794032:C:G | G82R | 0.877 |
| 7:150794032:C:T | G82R | 0.877 |
| 7:150792167:G:C | F203L | 0.875 |
| 7:150792167:G:T | F203L | 0.875 |
| 7:150792169:A:G | F203L | 0.875 |
| 7:150793197:C:G | C164S | 0.872 |
| 7:150793198:A:T | C164S | 0.872 |
| 7:150793976:G:C | F100L | 0.870 |
| 7:150793976:G:T | F100L | 0.870 |
| 7:150793978:A:G | F100L | 0.870 |
| 7:150794026:A:G | C84R | 0.858 |
| 7:150793969:C:A | G103W | 0.857 |
| 7:150794053:C:A | G75W | 0.856 |
| 7:150793969:C:G | G103R | 0.855 |
| 7:150793969:C:T | G103R | 0.855 |
| 7:150794031:C:T | G82E | 0.855 |
| 7:150793973:C:A | W101C | 0.852 |
dbSNP variants (sampled 300 via entrez): RS1000385570 (7:150801115 G>A,C,T), RS1000409615 (7:150798280 G>A), RS1000505564 (7:150791186 T>C), RS1000657366 (7:150792477 G>T), RS1000693691 (7:150800282 G>A,T), RS1000853523 (7:150801986 A>G,T), RS1001262339 (7:150791285 T>A,C), RS1001359282 (7:150796983 A>G), RS1001414967 (7:150796734 G>A), RS1001614821 (7:150794792 T>G), RS1001873796 (7:150802273 G>A,C,T), RS1002312715 (7:150796001 A>G), RS1002419102 (7:150795355 C>T), RS1002520192 (7:150803125 G>A,C), RS1002554835 (7:150802719 T>C)
Disease associations
OMIM: gene MIM:610385 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010083_191 | Hemoglobin levels | 2.000000e-10 |
| GCST90000025_316 | Appendicular lean mass | 2.000000e-15 |
| GCST90002383_440 | Hematocrit | 7.000000e-14 |
| GCST90002384_165 | Hemoglobin | 7.000000e-14 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004509 | hemoglobin measurement |
| EFO:0004980 | appendicular lean mass |
| EFO:0004348 | hematocrit |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
23 total (human), top 23 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects methylation, decreases expression, increases expression | 3 |
| Acetaminophen | decreases expression, increases expression | 2 |
| Benzo(a)pyrene | affects methylation, decreases expression, increases methylation | 2 |
| Tobacco Smoke Pollution | decreases expression, decreases methylation | 2 |
| Cyclosporine | decreases expression | 2 |
| Aflatoxin B1 | affects expression, decreases methylation | 2 |
| FR900359 | decreases phosphorylation | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol S | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Amphotericin B | decreases expression | 1 |
| Calcitriol | decreases expression | 1 |
| Diazinon | increases methylation | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Doxorubicin | increases expression | 1 |
| Methotrexate | decreases expression | 1 |
| Nickel | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| 1-Methyl-4-phenylpyridinium | increases expression | 1 |
| Antirheumatic Agents | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.